The Dipna Pharmachem IPO is a closed SME Fixed Price offer (Fresh Capital) that opened on 25 August 2022. The Dipna Pharmachem IPO closed on 30 August 2022, with an issue price of ₹38 per share. The Dipna Pharmachem IPO has a face value of ₹10 and a lot size of 3,000 shares. The Dipna Pharmachem IPO is listed on 8 September 2022.
On the financial front, the Dipna Pharmachem IPO reported revenue of ₹3,055 for 31-Mar-20, compared with ₹3,102 for 31-Mar-21. The Dipna Pharmachem IPO PAT was ₹6 against ₹2. The Dipna Pharmachem IPO net worth as of 31-Mar-20 was ₹55.
Always verify The Dipna Pharmachem IPO details and GMP data with the official offer document before investing in the Dipna Pharmachem IPO.
Financial Summary
Amount in Lakhs
Metric
31-Mar-20
31-Mar-21
31-Mar-22
Total Assets
1,844
2,479
3,623
Revenue
3,055
3,102
7,277
PAT
6
2
117
Net Worth
55
57
174
Reserves
51
54
170
Dipna Pharmachem IPO Financials FAQs
Revenue of Dipna Pharmachem (Amount in Lakhs) — 31-Mar-20: 3,055; 31-Mar-21: 3,102; 31-Mar-22: 7,277. Profit after tax (PAT) — 31-Mar-20: 6; 31-Mar-21: 2; 31-Mar-22: 117.
The financials shown for Dipna Pharmachem IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
